Assembly Biosciences Stock In The News

ASMB Stock  USD 17.93  0.03  0.17%   
Our overall analysis of Assembly Biosciences' news coverage and content from conventional and social sources shows investors' bearish mood towards Assembly Biosciences. The specific impact of Assembly Biosciences news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Assembly Biosciences' overall financial health and prospects. It also depends on the type and quality of a news publisher. Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Assembly Biosciences headlines in addition to utilizing other, more conventional financial analysis modules. Check out Assembly Biosciences Backtesting and Assembly Biosciences Hype Analysis.
For information on how to trade Assembly Stock refer to our How to Trade Assembly Stock guide.

Assembly Biosciences Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
Assembly Biosciences Presents Data Highl...
https://www.globenewswire.com/news-release/2025/07/26/3122076/16259/en/Assembly-Biosciences-Presents-Data-Highlighting-Recurrent-Genital-Herpes-Program-at-STI-HIV-2025-World-Congress-and-International-Herpesvirus-Workshop.html
 Bullish
Yahoo News
Assembly Bio’s (ASMB) HBV Drug Shows Strong Efficacy in Phase 1b Trial
https://finance.yahoo.com/news/assembly-bio-asmb-hbv-drug-034806498.html
 Bullish
Yahoo News
Assembly Biosciences, Inc. (ASMB) Announces Key Leadership and Plan Changes
https://finance.yahoo.com/news/assembly-biosciences-inc-asmb-announces-020910124.html
 Bullish
Yahoo News
Assembly Biosciences Says First Participant Dosed in Phase 1b Study of HSV Drug ABI-1179
https://finance.yahoo.com/news/assembly-biosciences-says-first-participant-150828761.html
 Neutral
Investing News at Macroaxis
Assembly Bio reports positive results from HBV drug trial
https://www.investing.com/news/company-news/assembly-bio-reports-positive-results-from-hbv-drug-trial-93CH-4110306
 Bullish
Macroaxis News: globenewswire.com
Assembly Biosciences Reports Positive To...
https://www.globenewswire.com/news-release/2025/06/25/3105003/16259/en/Assembly-Biosciences-Reports-Positive-Topline-Results-from-Phase-1b-Clinical-Trial-of-Next-Generation-Investigational-Capsid-Assembly-Modulator-ABI-4334-in-Chronic-Hepatitis-B.html
 Neutral
Yahoo News
Assembly Biosciences Reports Positive To...
https://finance.yahoo.com/news/assembly-biosciences-reports-positive-topline-120000228.html
 Neutral
Macroaxis News: globenewswire.com
Assembly Biosciences to Present During the Jefferies 2025 Global Healthcare Conference
https://www.globenewswire.com/news-release/2025/05/27/3088989/16259/en/Assembly-Biosciences-to-Present-During-the-Jefferies-2025-Global-Healthcare-Conference.html
 Neutral
Macroaxis News: globenewswire.com
Assembly Biosciences Reports First Quarter 2025 Financial Results and Recent Updates
https://www.globenewswire.com/news-release/2025/05/08/3077684/16259/en/Assembly-Biosciences-Reports-First-Quarter-2025-Financial-Results-and-Recent-Updates.html
 Bullish
Macroaxis News: globenewswire.com
Assembly Biosciences Presents New Data H...
https://www.globenewswire.com/news-release/2025/04/09/3058117/16259/en/Assembly-Biosciences-Presents-New-Data-Highlighting-Long-Acting-Herpes-Simplex-Virus-Candidate-ABI-5366-and-Genital-Herpes-Prevalence-and-Treatment-Patterns-at-the-2025-ESCMID-Cong.html
 Neutral

Assembly Biosciences Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Assembly and other traded companies coverage with news coverage. We help investors stay connected with Assembly headlines for the 1st of August to make an informed investment decision based on correlating the impacts of news items on Assembly Stock performance. Please note that trading solely based on the Assembly Biosciences hype is not for everyone as timely availability and quick action are needed to avoid losses.
Assembly Biosciences' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Assembly Biosciences investors visualize upcoming and past events in order to time the market based on Assembly Biosciences noise-free hype analysis.

Assembly Biosciences Investors Sentiment

The influence of Assembly Biosciences' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Assembly. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Assembly Biosciences' public news can be used to forecast risks associated with an investment in Assembly. The trend in average sentiment can be used to explain how an investor holding Assembly can time the market purely based on public headlines and social activities around Assembly Biosciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Assembly Biosciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Assembly Biosciences' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Assembly Biosciences' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Assembly Biosciences.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Assembly Biosciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Assembly Biosciences' short interest history, or implied volatility extrapolated from Assembly Biosciences options trading.
When determining whether Assembly Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Assembly Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Assembly Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Assembly Biosciences Stock:
Check out Assembly Biosciences Backtesting and Assembly Biosciences Hype Analysis.
For information on how to trade Assembly Stock refer to our How to Trade Assembly Stock guide.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Assembly Biosciences. If investors know Assembly will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Assembly Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(6.20)
Revenue Per Share
4.939
Quarterly Revenue Growth
0.628
Return On Assets
(0.25)
Return On Equity
(1.34)
The market value of Assembly Biosciences is measured differently than its book value, which is the value of Assembly that is recorded on the company's balance sheet. Investors also form their own opinion of Assembly Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Assembly Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Assembly Biosciences' market value can be influenced by many factors that don't directly affect Assembly Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Assembly Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Assembly Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Assembly Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.